Drugs that lack single-agent activity: are they worth pursuing in combination?

被引：26

作者：

Gyawali, Bishal ^{[1
]}

Prasad, Vinay ^{[2
,3
,4
]}

机构：

[1] Nobel Hosp, Dept Haematooncol, Kathmandu 21034, Nepal

[2] OSHU, Div Hematol Oncol, Knight Canc Inst, Portland, OR 97239 USA

[3] OSHU, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA

[4] Ctr Eth Hlth Care, 3181 South West Sam Jackson Pk Rd, Portland, OR 97239 USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2017年 / 14卷 / 04期

关键词：

METASTATIC BREAST-CANCER; MULTIPLE-MYELOMA; TRIAL; MULTICENTER; DOXORUBICIN; BORTEZOMIB;

D O I：

10.1038/nrclinonc.2017.27

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Over the past decade, many anticancer drugs have been approved for use only in combination regimens and only in palliative settings, despite having negligible single-agent activity in the same disease. We examine whether these agents provide any tangible clinical benefits and are worthy of continued development, or whether R&D efforts would be better focused elsewhere.

引用

页码：1 / 2

页数：2

共 50 条

[1] Drugs that lack single-agent activity: are they worth pursuing in combination?
Bishal Gyawali
Vinay Prasad
Nature Reviews Clinical Oncology, 2017, 14 : 193 - 194
[2] New investigational drugs with single-agent activity in multiple myeloma
A M Rajan
S Kumar
Blood Cancer Journal, 2016, 6 : e451 - e451
[3] New investigational drugs with single-agent activity in multiple myeloma
Rajan, A. M.
Kumar, S.
BLOOD CANCER JOURNAL, 2016, 6 : e451 - e451
[4] Novel PARP inhibitors with potent antitumor activity as single-agent and combination therapies
Wang, Bing
Chu, Daniel
Feng, Ying
Yu, Xin
Myers, Peter
Post, Leonard
Shen, Yucliao
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[5] REVIEW OF ETOPOSIDE SINGLE-AGENT ACTIVITY
SCHMOLL, H
CANCER TREATMENT REVIEWS, 1982, 9 : 21 - 30
[6] SINGLE-AGENT AND COMBINATION THERAPY OF ESSENTIAL-HYPERTENSION
WEBER, MA
DRAYER, JIM
AMERICAN HEART JOURNAL, 1984, 108 (02) : 311 - 316
[7] Single-agent and combination biologics in acute myeloid leukemia
Richard-Carpentier, Guillaume
DiNardo, Courtney D.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 548 - 556
[8] Single-Agent Therapies After Standard Combination Regimens
Chokshi, Saurin
Hochster, Howard S.
CANCER JOURNAL, 2016, 22 (03): : 205 - 210
[9] THE ACTIVITY OF SINGLE-AGENT CARBOPLATIN IN ADVANCED SEMINOMA
HORWICH, A
DEARNALEY, DP
AHERN, R
MASON, M
THOMAS, G
JAY, G
NICHOLLS, J
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) : 1307 - 1310
[10] Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: Single-agent and combination studies
Foss, FM
SEMINARS IN ONCOLOGY, 2000, 27 (02) : 58 - 63

← 1 2 3 4 5 →